Roles of hypertension in the rupture of intracranial aneurysms

Stroke

Volumn 45, Issue 2, 2014, Pages 579-586

  Tada, Yoshiteru ^a,b   Wada, Kosuke ^a   Shimada, Kenji ^a   Makino, Hiroshi ^a   Liang, Elena I ^a   Murakami, Shoko ^a   Kudo, Mari ^a   Kitazato, Keiko T ^b   Nagahiro, Shinji ^b   Hashimoto, Tomoki ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Angiotensins; Hypertension; Intracranial aneurysm; Models, animal; Subarachnoid hemorrhage

Indexed keywords

CAPTOPRIL; DEOXYCORTICOSTERONE ACETATE; ELASTASE; HYDRALAZINE; LOSARTAN;

ANIMAL EXPERIMENT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL WALL; BRAIN ARTERY ANEURYSM RUPTURE; CEREBROSPINAL FLUID; CLINICAL ASSESSMENT; CONTROLLED STUDY; DRUG EFFICACY; HYPERTENSION; MALE; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK REDUCTION; SUBARACHNOID HEMORRHAGE; TREATMENT DURATION;

ANGIOTENSINS; HYPERTENSION; INTRACRANIAL ANEURYSM; MODELS, ANIMAL; SUBARACHNOID HEMORRHAGE;

ANEURYSM, RUPTURED; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CAPTOPRIL; DESOXYCORTICOSTERONE ACETATE; DOSE-RESPONSE RELATIONSHIP, DRUG; HYDRALAZINE; HYPERTENSION; INTRACRANIAL ANEURYSM; LOSARTAN; MALE; MICE; MICE, INBRED C57BL; PANCREATIC ELASTASE; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS; SUBARACHNOID HEMORRHAGE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84893815565     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.113.003072     Document Type: Article

References (31)

1. Schievink WI. Intracranial aneurysms. N Engl J Med. 1997;336:28-40.
2. Connolly ES Jr, Rabinstein AA, Carhuapoma JR, Derdeyn CP, Dion J, Higashida RT, et al; American Heart Association Stroke Council; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; Council on Cardiovascular Surgery and Anesthesia; Council on Clinical Cardiology. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association. Stroke. 2012;43:1711-1737.
3. Wiebers DO, Whisnant JP, Huston J III, Meissner I, Brown RD Jr, Piepgras DG, et al; International Study of Unruptured Intracranial Aneurysms Investigators. Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet. 2003;362:103-110.
4. TISoUIA Investigators. Unruptured intracranial aneurysms-risk of rupture and risks of surgical intervention. International Study of Unruptured Intracranial Aneurysms Investigators. N Engl J Med. 1998;339:1725-1733.
5. Juvela S. Recommendations for the management of patients with unruptured intracranial aneurysms. Stroke. 2001;32:815-816.
6. Hashimoto N, Handa H, Hazama F. Experimentally induced cerebral aneurysms in rats. Surg Neurol. 1978;10:3-8.
7. Hashimoto N, Handa H, Hazama F. Experimentally induced cerebral aneurysms in rats: part II. Surg Neurol. 1979;11:243-246.
8. Hashimoto T, Meng H, Young WL. Intracranial aneurysms: links between inflammation, hemodynamics and vascular remodeling. Neurol Res. 2006;28:372-380.
9. Nuki Y, Tsou TL, Kurihara C, Kanematsu M, Kanematsu Y, Hashimoto T. Elastase-induced intracranial aneurysms in hypertensive mice. Hypertension. 2009;54:1337-1344.
10. Morimoto M, Miyamoto S, Mizoguchi A, Kume N, Kita T, Hashimoto N. Mouse model of cerebral aneurysm: experimental induction by renal hypertension and local hemodynamic changes. Stroke. 2002;33:1911-1915.
11. Muller M, van den Beld AW, Bots ML, Grobbee DE, Lamberts SW, van der Schouw YT. Endogenous sex hormones and progression of carotid atherosclerosis in elderly men. Circulation. 2004;109:2074-2079.
12. Keramatipour M, McConnell RS, Kirkpatrick P, Tebbs S, Furlong RA, Rubinsztein DC. The ACE I allele is associated with increased risk for ruptured intracranial aneurysms. J Med Genet. 2000;37:498-500.
13. Takenaka K, Yamakawa H, Sakai H, Yoshimura S, Murase S, Okumura A, et al. Angiotensin I-converting enzyme gene polymorphism in intracranial saccular aneurysm individuals. Neurol Res. 1998;20:607-611.
14. Slowik A, Borratynska A, Pera J, Betlej M, Dziedzic T, Krzyszkowski T, et al. II genotype of the angiotensin-converting enzyme gene increases the risk for subarachnoid hemorrhage from ruptured aneurysm. Stroke. 2004;35:1594-1597.
15. Kanematsu Y, Kanematsu M, Kurihara C, Tsou TL, Nuki Y, Liang EI, et al. Pharmacologically induced thoracic and abdominal aortic aneurysms in mice. Hypertension. 2010;55:1267-1274.
16. Tada Y, Kanematsu Y, Kanematsu M, Nuki Y, Liang EI, Wada K, et al. A mouse model of intracranial aneurysm: technical considerations. Acta Neurochir Suppl. 2011;111:31-35.
17. Makino H, Tada Y, Wada K, Liang EI, Chang M, Mobashery S, et al. Pharmacological stabilization of intracranial aneurysms in mice: a feasibility study. Stroke. 2012;43:2450-2456.
18. Kanematsu Y, Kanematsu M, Kurihara C, Tada Y, Tsou TL, van Rooijen N, et al. Critical roles of macrophages in the formation of intracranial aneurysm. Stroke. 2011;42:173-178.
19. Weiss D, Taylor WR. Deoxycorticosterone acetate salt hypertension in apolipoprotein E-/- mice results in accelerated atherosclerosis: the role of angiotensin II. Hypertension. 2008;51:218-224.
20. Wilson RM, De Silva DS, Sato K, Izumiya Y, Sam F. Effects of fixed- dose isosorbide dinitrate/hydralazine on diastolic function and exercise capacity in hypertension-induced diastolic heart failure. Hypertension. 2009;54:583-590.
21. Mercure C, Prescott G, Lacombe MJ, Silversides DW, Reudelhuber TL. Chronic increases in circulating prorenin are not associated with renal or cardiac pathologies. Hypertension. 2009;53:1062-1069.
22. Dilauro M, Zimpelmann J, Robertson SJ, Genest D, Burns KD. Effect of ACE2 and angiotensin-(1-7) in a mouse model of early chronic kidney disease. Am J Physiol Renal Physiol. 2010;298:F1523-F1532.
23. Katz SA, Opsahl JA, Wernsing SE, Forbis LM, Smith J, Heller LJ. Myocardial renin is neither necessary nor sufficient to initiate or maintain ventricular hypertrophy. Am J Physiol Regul Integr Comp Physiol. 2000;278:R578-R586.
24. Gabriel RA, Kim H, Sidney S, McCulloch CE, Singh V, Johnston SC, et al. Ten-year detection rate of brain arteriovenous malformations in a large, multiethnic, defined population. Stroke. 2010;41:21-26.
25. Loumiotis I, Wagenbach A, Brown RD Jr, Lanzino G. Small (< 10-mm) incidentally found intracranial aneurysms, Part 1: reasons for detection, demographics, location, and risk factors in 212 consecutive patients. Neurosurg Focus. 2011;31:E3.
26. Brisman JL, Song JK, Newell DW. Cerebral aneurysms. N Engl J Med. 2006;355:928-939.
27. Bederson JB, Awad IA, Wiebers DO, Piepgras D, Haley EC Jr, Brott T, et al. Recommendations for the management of patients with unruptured intracranial aneurysms: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke. 2000;31:2742-2750.
28. Berman MF, Solomon RA, Mayer SA, Johnston SC, Yung PP. Impact of hospital-related factors on outcome after treatment of cerebral aneurysms. Stroke. 2003;34:2200-2207.
29. Zacharia BE, Ducruet AF, Hickman ZL, Grobelny BT, Badjatia N, Mayer SA, et al. Technological advances in the management of unruptured intracranial aneurysms fail to improve outcome in New York state. Stroke. 2011;42:2844-2849.
30. Aoki T, Nishimura M, Kataoka H, Ishibashi R, Nozaki K, Hashimoto N. Reactive oxygen species modulate growth of cerebral aneurysms: a study using the free radical scavenger edaravone and p47phox(-/-) mice. Lab Invest. 2009;89:730-741.
31. Ohkuma H, Suzuki S, Fujita S, Nakamura W. Role of a decreased expression of the local renin-angiotensin system in the etiology of cerebral aneurysms. Circulation. 2003;108:785-787.